LFVN
Lifevantage Corp
$6.24
-0.01 (-0.16%)
At close · Jul 10
Market Cap
$78.72M
Shares
12,615,822
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$228.53M
+14.2%
FY2025
Net Income
$9.81M
+233.8%
FY2025
Gross Margin
80.37%
+1.1pp
FY2025
Operating Margin
5.34%
+3.2pp
FY2025
Diluted EPS
$0.75
+226.1%
FY2025
Operating Cash Flow
$11.88M
-2.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $195.32M | $228.53M | $200.16M | $213.4M | $206.36M | $220.18M | $232.92M | $225.96M | $203.2M | $199.49M | $206.54M | $190.34M | $213.97M | $208.18M | $126.18M | $38.92M | |
| $42.7M | $44.86M | $41.44M | $43.39M | $38.1M | $38.19M | $37.96M | $37.97M | $34.85M | $33.46M | $33.93M | $28.01M | $33.19M | $31.85M | $18.05M | $5.92M | |
| $152.62M | $183.67M | $158.72M | $170.01M | $168.26M | $181.99M | $194.95M | $187.99M | $168.36M | $166.03M | $172.61M | $162.33M | $180.77M | $171.54M | $108.13M | $33M | |
| — | 80.37% | 79.3% | 79.67% | 81.54% | 82.66% | 83.7% | 83.19% | 82.85% | 83.23% | 83.57% | 85.28% | 84.49% | 82.4% | 85.69% | 84.8% | |
| $1.2M | $1.4M | $700K | $600K | $700K | $700K | $900K | $1.1M | $1.2M | $1.1M | $1M | $2.4M | $2M | $2.9M | $1.4M | $509K | |
| $125.92M | — | — | — | — | — | — | — | — | — | — | — | — | $122.39M | $68.4M | $21.06M | |
| $32.19M | — | — | — | — | — | — | — | — | — | — | — | — | $32.47M | $16.4M | $7.52M | |
| $63.22M | $69.21M | $68.47M | $71.07M | $63.43M | $60.84M | $67.91M | $69.55M | $59.84M | $64.92M | $56.07M | $57.35M | $56.8M | $57.73M | $28.72M | — | |
| — | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | $100K | |
| — | $3.16M | $3.58M | $3.58M | $3.26M | $3.46M | $2.78M | $1.9M | $1.33M | $1.64M | $1.9M | $2.29M | $2.12M | $1.66M | $521K | $215K | |
| $146.04M | $171.47M | $154.39M | $165.75M | $160.69M | $164.38M | $179.49M | $178.17M | $158.03M | $161.58M | $159.19M | $148.43M | $161.33M | $159.47M | $86.67M | $29.3M | |
| $6.58M | $12.2M | $4.33M | $4.26M | $7.58M | $17.62M | $15.47M | $9.81M | $10.32M | $4.45M | $13.41M | $13.9M | $19.45M | $12.07M | $21.46M | $3.7M | |
| — | 5.34% | 2.16% | 2% | 3.67% | 8% | 6.64% | 4.34% | 5.08% | 2.23% | 6.49% | 7.3% | 9.09% | 5.8% | 17% | 9.51% | |
| — | $15.36M | $7.91M | $7.84M | $10.84M | $21.08M | $18.24M | $11.71M | $11.65M | $6.09M | $15.31M | $16.18M | $21.57M | $13.73M | $21.98M | $3.92M | |
| — | — | -$430K | -$198K | $10K | $17K | $120K | $323K | $456K | $570K | $3.32M | $3.09M | $3.18M | $3000 | $8000 | $5.99M | |
| $185K | $44K | $18K | -$260K | -$2.88M | -$383K | -$805K | -$584K | -$775K | -$1.54M | -$4.73M | -$3.25M | -$2.79M | -$915K | -$6.79M | -$54.4M | |
| $6.77M | $12.24M | $4.35M | $4M | $4.69M | $17.23M | $14.66M | $9.23M | $9.55M | $2.91M | $8.68M | $10.65M | $16.66M | $11.15M | $14.67M | -$50.7M | |
| $1.01M | $2.44M | $1.41M | $1.46M | $1.57M | $4.34M | $3.11M | $1.8M | $3.79M | $1.3M | $2.58M | $3.53M | $5.27M | $3.55M | $2.2M | $92K | |
| $5.75M | $9.81M | $2.94M | $2.54M | $3.12M | $12.89M | $11.55M | $7.43M | $5.76M | $1.61M | $6.11M | $7.13M | $11.38M | $7.61M | $12.47M | -$50.79M | |
| — | 4.29% | 1.47% | 1.19% | 1.51% | 5.86% | 4.96% | 3.29% | 2.84% | 0.81% | 2.96% | 3.74% | 5.32% | 3.65% | 9.88% | -130.51% | |
| USD/shares | — | $0.80 | $0.24 | $0.20 | $0.24 | $0.92 | $0.82 | $0.53 | $0.41 | $0.12 | $0.44 | $0.51 | $0.75 | $0.07 | $0.12 | -$0.69 |
| USD/shares | — | $0.75 | $0.23 | $0.20 | $0.24 | $0.90 | $0.79 | $0.50 | $0.41 | $0.11 | $0.42 | $0.50 | $0.71 | $0.06 | $0.11 | -$0.69 |
| shares | — | 12.25M | 12.46M | 12.56M | 12.89M | 14.07M | 14.11M | 14.06M | 13.99M | 13.88M | 13.73M | 13.9M | 15.11M | 112.28M | 102.7M | 73.17M |
| shares | — | 12.99M | 12.99M | 12.57M | 13.07M | 14.27M | 14.6M | 14.98M | 14.14M | 14.12M | 14.53M | 14.15M | 15.94M | 122.89M | 118.33M | 73.17M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2025: $106.85M in buybacks, $10.97M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Packaged Foods median 1.26×
EV/EBIT
—
Packaged Foods median 19.08×
P/E (TTM)
13.57×
Packaged Foods median 15.31×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Reportable Segment | $228,530,000 | $200,164,000 |
By Geography (USD)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| United States | $178,442,000 | $145,679,000 | $148,522,000 | $130,932,000 | $144,897,000 | $155,480,000 | $151,966,000 | $142,452,000 |
| Non Us | $50,088,000 | $54,485,000 | — | — | — | — | — | — |
| Japan | $25,394,000 | $26,989,000 | $32,082,000 | $36,810,000 | $41,173,000 | $42,343,000 | $40,796,000 | $41,843,000 |
| Other Foreign | $24,694,000 | $27,496,000 | — | — | — | — | — | — |
| Asia Pacific and Europe | — | $47,257,000 | $58,037,000 | $68,037,000 | $65,526,000 | $66,579,000 | $62,722,000 | $51,595,000 |
| Americas | — | $152,907,000 | $155,361,000 | $138,323,000 | $154,655,000 | $166,336,000 | $163,236,000 | $151,609,000 |
By Product & Service (USD)
| Component | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 |
|---|---|---|---|---|---|---|---|---|
| Protandim | $95,328,000 | $104,135,000 | $119,720,000 | $135,616,000 | $150,272,000 | $156,335,000 | $144,100,000 | $130,094,000 |
| LifeVantage True Science Skin Care Regimen | $56,225,000 | $15,675,000 | $49,494,000 | $22,877,000 | $22,617,000 | $23,739,000 | $24,853,000 | $20,881,000 |
| TrueScience Product Line | $48,712,000 | $56,252,000 | — | — | — | — | — | — |
| AXIO Product Line | $15,312,000 | $13,375,000 | — | — | — | — | — | — |
| Product And Service Other | $5,734,000 | $4,502,000 | $44,184,000 | $47,867,000 | $47,292,000 | $52,841,000 | $57,005,000 | $52,229,000 |
| PhysIQ Product Line | $5,102,000 | $3,827,000 | — | — | — | — | — | — |
| Petandim Product Line | $2,117,000 | $2,398,000 | — | — | — | — | — | — |